SCHEMBL24812914

SCHEMBL24812914

CNC(=O)[C@H](CCCc1ccccc1O)NC(=O)OC(C)(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 10/20 0.52
▸ CTSS P25774 7/20 0.52
▸ MMP1 P03956 1/20 0.49
▸ MMP3 P08254 1/20 0.49
▸ MMP9 P14780 1/20 0.49
▸ HDAC4 P56524 4/20 0.48
▸ HDAC1 Q13547 4/20 0.48
▸ HDAC3 O15379 2/20 0.47
▸ HDAC7 Q8WUI4 2/20 0.47
▸ HDAC2 Q92769 2/20 0.47
▸ HDAC10 Q969S8 2/20 0.47
▸ HDAC11 Q96DB2 2/20 0.47
▸ HDAC8 Q9BY41 2/20 0.47
▸ HDAC6 Q9UBN7 2/20 0.47
▸ HDAC9 Q9UKV0 2/20 0.47
▸ HDAC5 Q9UQL6 2/20 0.47
▸ CTSL P07711 1/20 0.43
▸ CTSB P07858 1/20 0.43
▸ JAK3 P52333 1/20 0.43
▸ BTK Q06187 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29178324 1.00 CTSK (0.52) CTSKCTSSMMP1MMP3MMP9
SCHEMBL30049273 1.00 CTSK (0.52) CTSKCTSSMMP1MMP3MMP9
SCHEMBL29178423 0.84 MMP3 (0.64) CTSKCTSSMMP1MMP3MMP9
SCHEMBL24814567 0.84 MMP3 (0.64) CTSKCTSSMMP1MMP3MMP9
SCHEMBL25139423 0.83 MMP1 (0.45) MMP1MMP3MMP9
SCHEMBL6550878 0.82 CTSS (0.74) CTSKCTSSMMP1MMP3MMP9
SCHEMBL13669553 0.82 CTSS (0.74) CTSKCTSSMMP1MMP3MMP9
SCHEMBL12890034 0.82 CTSS (0.74) CTSKCTSSMMP1MMP3MMP9
SCHEMBL25139698 0.81 CTSK (0.54) CTSKCTSSMMP1MMP3MMP9
SCHEMBL29178351 0.81 CTSK (0.54) CTSKCTSSMMP1MMP3MMP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022272106-A1 CDK2 INHIBITORS AND METHODS OF USING THE SAME CEDILLA THERAPEUTICS, INC. (US) 2022-12-29 — — WO disclosed
Send feedback